One-Step Radiolabelling of Tropanamine Derivatives
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current radiolabelling processes for tropanamine derivatives used in PET imaging of the neuronal dopamine transporter are often multi-step, requiring large amounts of precursors, leading to increased impurities and exposure to radioactivity, and are not suitable for high-yield, high-purity production of fluorine-18 labelled compounds.
Innovation Solution
A one-step radiochemical process using compounds of formula (II) that react with a source of 18F anion in the presence of a base, allowing for the direct labelling of tropanamine derivatives with fluorine-18, reducing precursor requirements and enhancing radiolabelling yields and purity, while minimizing exposure to radioactivity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If multi-step radiolabelling processes are used for tropanamine derivatives, then labelling can be achieved, but precursor amounts must be large leading to increased impurities and exposure to radioactivity
Solution Approach 1:
The patent combines multiple radiolabelling steps into a single one-step process. The general formula (II) represents a precursor that contains multiple potential labelling sites, allowing 18F incorporation to occur in a single reaction step rather than requiring sequential multi-step labelling, thereby reducing precursor consumption and improving purity
Solution Approach 2:
The patent changes the chemical parameters of the labelling process by using a novel precursor structure with specific functional groups (halogen, pseudohalogen, or leaving group) that enable direct 18F substitution. This parameter change in the precursor's chemical structure allows for more efficient single-step labelling with reduced precursor requirements
2Reliability
If multi-step radiolabelling processes are used, then labelling can be achieved, but exposure to radioactivity increases
Solution Approach 1:
The one-step radiolabelling process allows the radioactive 18F to be incorporated into the final product in a single reaction step, skipping intermediate isolation and purification steps. This rushes through the labelling process more quickly, reducing the total time operators are exposed to radioactivity while maintaining high radiolabelling yields
3Productivity
If large amounts of precursors are used, then radiolabelling can proceed, but impurity levels increase
Solution Approach 1:
The patent extracts or removes unnecessary intermediate steps from the traditional multi-step radiolabelling process. By designing a precursor with pre-installed functional groups that are ready for direct 18F substitution, the method eliminates intermediate labelling steps that would otherwise require additional precursor and generate impurities, thereby improving both efficiency and purity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method achieves high radiolabelling yields and purity with reduced precursor amounts, enabling safer, more efficient production of fluorine-18 labelled compounds suitable for PET imaging, particularly for the highly selective dopamine transporter ligand LBT-999.
Implementation Method 1
reacting a compound of formula (II) with a source of 18F anion in the presence of a base, allowing for the direct labelling of tropanamine derivatives with fluorine-18
Data Source
AI summary
The invention relates to a one-step [18F]radiolabelling process of tropanamine derivatives which are useful for imaging the neuronal dopamine transporter (DAT) with Positron Emission Tomography (PET).